4.7 Review

SUMOylation in Glioblastoma: A Novel Therapeutic Target

Journal

Publisher

MDPI
DOI: 10.3390/ijms20081853

Keywords

glioblastoma (GBM); SUMOylation; SUMO1-3; post-translational modifications (PTMs)

Funding

  1. University of Alabama at Birmingham Medical Scientist Training Program (MSTP)
  2. Rally Foundation for Childhood Cancer Research
  3. Hyundai Hope on Wheels
  4. Department of Defense [W81XWH-15-1-0108]

Ask authors/readers for more resources

Protein SUMOylation is a dynamic post-translational modification which is involved in a diverse set of physiologic processes throughout the cell. Of note, SUMOylation also plays a role in the pathobiology of a myriad of cancers, one of which is glioblastoma (GBM). Accordingly, herein, we review core aspects of SUMOylation as it relates to GBM and in so doing highlight putative methods/modalities capable of therapeutically engaging the pathway for treatment of this deadly neoplasm.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available